The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has launched its Global Radiopharmaceutical Trial Finder.
This AI-powered platform is intended to help researchers, clinicians, and patients find radiopharmaceutical clinical trials that meet their specific needs. Developed by Ancora.ai and hosted on the SNMMI website, the Trial Finder uses real-time global trials data refreshed every 24 hours from ClinicalTrials.gov and three additional international registries. No personal information is stored or sold, the SNMMI said.
Users are guided through specific questions about disease stage, prior treatment, and other key factors. What returns is a tailored list of trials for which patients may be eligible or trials that researchers may be interested in monitoring. Each result includes the strength of the match to the trial criteria and the trial site's distance from an entered location.
More information on the Trial Finder can be found on the SNMMI's site.
